GTx G300504

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Gtx-024 on Muscle Wasting in Patients with Non-Small Cell Lung Cancer on First-Line Platinum Plus a Taxane Chemotherapy.